Type 2 Diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention Group: Patients with type 2 Diabetes receive 2 Familact Probiotic Capsules twice per day (After lunch and after dinner), for 6 weeks. Each capsule contains 500 mg Probioti
Treatment - Drugs
Placebo
Intervention Group: Patients with type 2 Diabetes receive 2 Familact Probiotic Capsules twice per day (After lunch and after dinner), for 6 weeks. Each capsule contains 500 mg Probiotics which precise
Placebo Group: Receiving 2 Placebo Capsules twice per day (after lunch and dinner), containing 1000 mg Magnesium Stearate for 6 weeks.
Sponsors
Vice chancellor of Shahid Beheshti Endocrinology Research center
Vice chancellor of Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Having type 2 diabetes mellitus; the age range was 25 to 65 years with a fifteen-year maximal period of type 2 diabetes mellitus ; controlled glucose and lipid levels of the patients were considered ; taking drugs prescribed by doctors were permitted until their dosages were unchanged during the intervention. Exclusion criteria: Having replacement treatments like Hormone or supplemental vitamins ; tobacco and alcohol use ; clinical signs of chronic kidney, liver or pulmonary disease ; chronic or acute inflammatory disease (especially acute pancreatic inflammation and Endocarditis) ; heart valve disease ; short bowel syndrome ; allergies ; immunosuppressives ; pregnancy and lactation and taking less than 10% of probiotic or placebo supplements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: Baseline, and after 6 weeks. Method of measurement: Biochemical Analysis.;Serum Insulin. Timepoint: Baseline and after 6 weeks. Method of measurement: ELIZA.;HOMA-IR. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Lipid profile: Total cholesterol, Triglyceride, HDL-C, LDL-C. Timepoint: Baseline and after 6 weeks. Method of measurement: Biochemical Analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dietary Factors. Timepoint: Baseline and after 6 weeks. Method of measurement: 24 hour and 3-day dietary Recall.;Body Mass Index. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Waist Circumference. Timepoint: Baseline and after 6 weeks. Method of measurement: Inelastic Plastic Tape.;Hip Circumference. Timepoint: Baseline and after 6 weeks. Method of measurement: Inelastic Plastic Tape.;Waist to Hip Ratio. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Parvin Mirmiran
Shahid Beheshti Endocrinology Research Center
Outcome results
None listed